Bayer says that it today commenced the previously announced public takeover offer for all the shares of Norwegian pharmaceutical company Algeta (Oslo) for 362 Norwegian kroner ($59) in cash per Algeta share. The offer values the total share capital of Algeta at about 17.6 billion Norwegian kroner. Bayer raised its offer for Algeta after initially offering to pay 336 Norwegian kroner per Algeta share. Bayer today issued the takeover offer on the basis of the agreement signed with Algeta on 19 December 2013. The offer period starts on 20 January and expires on 24...